Darapladib T6109
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Darapladib(IC50=0.25 nM) is a substituted pyrimidone with inhibitory activity towards lipoprotein-associated phospholipase-A2 (Lp-PLA2).
CAS nr:
356057-34-6
Purity:
98%
Molecular Weight:
666,77
SMILES:
CCN(CC)CCN(Cc1ccc(cc1)c1ccc(cc1)C(F)(F)F)C(=O)Cn1c2c(CCC2)c(=O)nc1SCc1ccc(cc1)F
Formula:
C36H38F4N4O2S
Pathway:
Metabolism
Target:
Phospholipase
